摘要:
The present invention relates to the field of cancer and inflammatory diseases. Specifically, the purpose of said invention is to provide novel conjugated forms of active principles belonging to the family of dolastatins and of formula (I). In addition, said invention is aimed at prodrug forms of said conjugates.
摘要:
The present invention relates to a compound of general formula (I) in which: - X is OH, NH 2 , NHOH or RNH, wherein R may be a linear or branched, saturated or unsaturated, C1-C10 alkyl radical, - Y is H, or an electron-withdrawing group, in particular selected from NO 2 , CF 3 or a halogen, - R1 and R2 are H or a linear or branched, saturated or unsaturated, C1-C10 alkyl radical, - F is a reactive functional group that can be activated by click chemistry.
摘要:
La présente invention se rapporte au domaine du cancer et des maladies inflammatoires. Plus particulièrement, elle vise à proposer à ses fins des nouvelles formes conjuguées de principes actifs appartenant à la famille des dolastatines et de formule comme suit :
Elle vise, en outre, des formes pro-drogues de ces conjugués.